The Cooper Companies, Inc. (ticker: COO) has been making waves with its financial performance, market moves, and upcoming trends reflected in a range of announcements and predictions concerning the corporation. Their
Q1 and Q4 earnings met and beat estimates, with shareholders generating a
7.5% CAGR over the last five years. Despite growth,
stock dips accompanied earnings releases and analysts' assessments swung between
bullish and bearish outlooks. Concerns have been raised regarding Cooper's
use of debt and
returns on capital. Looking ahead, modest earnings are expected for Q1 2025 and the company provided strong 2025 revenue guidance. They have also announced a
4-for-1 stock split. The company is expanding through assorted acquisitions, including Cook Medical's reproductive health business for $875M and Generate Life Sciences. Despite these promising advancements, some forecasts have edged toward
pessimism while others have downgraded ratings or price targets. Yet, Cooper maintains a consensus rating of 'Moderate Buy'. Notably, the company's revenue projections have been deemed short of expectations, and they have recently faced lawsuits pertaining to a potential IVF mix-up.
The Cooper Companies COO News Analytics from Wed, 11 Nov 1992 08:00:00 GMT to Mon, 17 Mar 2025 19:13:50 GMT -
Rating 4
- Innovation 7
- Information 5
- Rumor 3
